These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 35882218)

  • 1. Multi-scale discriminative regions analysis in FDG-PET imaging for early diagnosis of Alzheimer's disease.
    Zhang J; He X; Qing L; Xu Y; Liu Y; Chen H
    J Neural Eng; 2022 Aug; 19(4):. PubMed ID: 35882218
    [No Abstract]   [Full Text] [Related]  

  • 2. Deep learning based diagnosis of Alzheimer's disease using FDG-PET images.
    Kishore N; Goel N
    Neurosci Lett; 2023 Nov; 817():137530. PubMed ID: 37858874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer's disease, and mild cognitive impairment using brain 18F-FDG PET.
    Etminani K; Soliman A; Davidsson A; Chang JR; Martínez-Sanchis B; Byttner S; Camacho V; Bauckneht M; Stegeran R; Ressner M; Agudelo-Cifuentes M; Chincarini A; Brendel M; Rominger A; Bruffaerts R; Vandenberghe R; Kramberger MG; Trost M; Nicastro N; Frisoni GB; Lemstra AW; van Berckel BNM; Pilotto A; Padovani A; Morbelli S; Aarsland D; Nobili F; Garibotto V; Ochoa-Figueroa M
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):563-584. PubMed ID: 34328531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.
    Khosravi M; Peter J; Wintering NA; Serruya M; Shamchi SP; Werner TJ; Alavi A; Newberg AB
    J Alzheimers Dis; 2019; 70(4):1197-1207. PubMed ID: 31322568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiscale spatial gradient features for
    Pan X; Adel M; Fossati C; Gaidon T; Wojak J; Guedj E;
    Comput Methods Programs Biomed; 2019 Oct; 180():105027. PubMed ID: 31430595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal FDG-PET features for the classification of Alzheimer's disease.
    Rodrigues F; Silveira M
    Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():1941-4. PubMed ID: 25570360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers.
    Xu L; Wu X; Li R; Chen K; Long Z; Zhang J; Guo X; Yao L;
    J Alzheimers Dis; 2016; 51(4):1045-56. PubMed ID: 26923024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-Modality Sparse Representation for Alzheimer's Disease Classification.
    Kwak K; Yun HJ; Park G; Lee JM;
    J Alzheimers Dis; 2018; 65(3):807-817. PubMed ID: 29562503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of dynamic susceptibility contrast enhanced MR and FDG-PET brain studies in patients with Alzheimer's disease and amnestic mild cognitive impairment.
    Wabik A; Trypka E; Bladowska J; Statkiewicz M; Sąsiadek M; Zimny A
    J Transl Med; 2022 Jun; 20(1):259. PubMed ID: 35672750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-View Separable Pyramid Network for AD Prediction at MCI Stage by
    Pan X; Phan TL; Adel M; Fossati C; Gaidon T; Wojak J; Guedj E
    IEEE Trans Med Imaging; 2021 Jan; 40(1):81-92. PubMed ID: 32894711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early differential diagnosis between Alzheimer's disease and dementia with Lewy bodies: Comparison between (18)F-FDG PET and (123)I-IMP SPECT.
    Chiba Y; Iseki E; Fujishiro H; Ota K; Kasanuki K; Suzuki M; Hirayasu Y; Arai H; Sato K
    Psychiatry Res Neuroimaging; 2016 Mar; 249():105-12. PubMed ID: 26857415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
    Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
    Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative multi-task feature selection for multi-modality classification of Alzheimer's disease.
    Ye T; Zu C; Jie B; Shen D; Zhang D;
    Brain Imaging Behav; 2016 Sep; 10(3):739-49. PubMed ID: 26311394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The accuracy of hippocampal volumetry and glucose metabolism for the diagnosis of patients with suspected Alzheimer's disease, using automatic quantitative clinical tools.
    Ferrari BL; Neto GCC; Nucci MP; Mamani JB; Lacerda SS; Felício AC; Amaro E; Gamarra LF
    Medicine (Baltimore); 2019 Nov; 98(45):e17824. PubMed ID: 31702636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-modal cross-attention network for Alzheimer's disease diagnosis with multi-modality data.
    Zhang J; He X; Liu Y; Cai Q; Chen H; Qing L
    Comput Biol Med; 2023 Aug; 162():107050. PubMed ID: 37269680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Joint Assessment of Quantitative 18F-Florbetapir and 18F-FDG Regional Uptake Using Baseline Data from the ADNI.
    Ben Bouallègue F; Mariano-Goulart D; Payoux P;
    J Alzheimers Dis; 2018; 62(1):399-408. PubMed ID: 29439345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment.
    Grimmer T; Wutz C; Alexopoulos P; Drzezga A; Förster S; Förstl H; Goldhardt O; Ortner M; Sorg C; Kurz A
    J Nucl Med; 2016 Feb; 57(2):204-7. PubMed ID: 26585056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-region analysis of longitudinal FDG-PET for the classification of Alzheimer's disease.
    Gray KR; Wolz R; Heckemann RA; Aljabar P; Hammers A; Rueckert D;
    Neuroimage; 2012 Mar; 60(1):221-9. PubMed ID: 22236449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCA and logistic regression in 2-[
    Gonçalves de Oliveira CE; de Araújo WM; de Jesus Teixeira ABM; Gonçalves GL; Itikawa EN
    Phys Med Biol; 2024 Jan; 69(2):. PubMed ID: 37976549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.